Safety Profile - Jakavi
Below is a selection of the observed side effects; please refer to the SmPc or the package leaflet for the complete list.
Myelosuppression
Patients who develop anaemia may need blood transfusions. Dose adjustment or...Twitter Linkedin Facebook Pinterest Google plusDosing / Administration
Posology The recommended dose is 40 mg twice daily at approximately 12‑hour intervals. If a dose is missed by less than 6 hours, it should be taken and the next dose should be taken as scheduled. If a dose is missed by more than...Twitter Linkedin Facebook Pinterest Google plusReimbursement / eHealth - Scemblix
Novartis Presentations at ESMO 2022
Efficacy
Safety Profile - Scemblix
Below is a selection of the observed side effects. Please refer to the SmPc for the complete list.
The most common adverse reactions of any grade (incidence ≥20%) in patients receiving asciminib were musculoskeletal pain (37.1%), upper...Twitter Linkedin Facebook Pinterest Google plusReimbursement - Jakavi
Heart Failure
Patient Resources - Entresto
Together for Better In the fight against heart failure condition, we work our hardest every day to develop innovative and effective medication to sustain a better life, keeping the patient in mind. We are aware that the result of...
Twitter Linkedin Facebook Pinterest Google plus